Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN13210908) titled 'ENDOCAN-1: A study to see if CBD (cannabinoid) can help with endometriosis-related pain' on March 3.
Study Type: Interventional
Study Design:
Interventional double blind randomized parallel group placebo controlled trial (Safety)
Primary Sponsor: University of Edinburgh and NHS Lothian
Condition:
Endometriosis
Urological and Genital Diseases
Intervention:
Participants will be randomised into one of two treatment arms, via an online randomisation tool.
CBD arm: participants in the active arm will be given oral CBD solution for 12 weeks duration. The starting dose will be a solution of 0.5 mg/kg BID administ...